Clinical Trial Update: A Phase IIA Study of BMS-512148 to Assess Safety, Exposure, and Biological Effects in Stable Type 2 Diabetic Subjects [Phase 2]

View source ↗

Summary

A Phase IIA study evaluated safety, exposure, and biological effects of BMS-512148 in adults with stable Type 2 diabetes mellitus, and the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-512148

Snippet

Sponsor: AstraZeneca | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED